Johnson & Johnson (JNJ)

NYSE: JNJ · IEX Real-Time Price · USD
182.29
+2.63 (1.46%)
Jun 24, 2022 4:00 PM EDT - Market closed
1.46%
Market Cap 479.68B
Revenue (ttm) 94.88B
Net Income (ttm) 19.83B
Shares Out 2.63B
EPS (ttm) 7.42
PE Ratio 24.57
Forward PE 16.89
Dividend $4.31 (2.36%)
Ex-Dividend Date May 23, 2022
Volume 9,374,446
Open 180.78
Previous Close 179.66
Day's Range 179.98 - 182.53
52-Week Range 155.72 - 186.69
Beta 0.66
Analysts Buy
Price Target 193.46 (+6.1%)
Earnings Date Jul 19, 2022

About JNJ

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; N... [Read more...]

Industry Pharmaceuticals
IPO Date Sep 24, 1944
CEO Alex Gorsky
Employees 144,000
Stock Exchange NYSE
Ticker Symbol JNJ
Full Company Profile

Financial Performance

In 2021, JNJ's revenue was $93.78 billion, an increase of 13.55% compared to the previous year's $82.58 billion. Earnings were $20.88 billion, an increase of 41.89%.

Financial Statements

Analyst Forecast

According to 24 analysts, the average rating for JNJ stock is "Buy." The 12-month stock price forecast is 193.46, which is an increase of 6.13% from the latest price.

Price Target
$193.46
(6.13% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Could Johnson & Johnson Stock Help You Retire A Millionaire?

Over the past decade, the stock has closely tracked the S&P 500.

Got $2,500? 2 Top Stocks That You Can Buy and Hold for a Lifetime

Being able to adapt to ever-changing environments is a critical characteristic of consistently successful companies.

Other symbols: MSFT

7 Large-Cap Stocks to Buy After the Next Big Correction

Large-cap stocks to buy with the broad market correction. Stocks to buy and hold for the long-term for dividends and stock upside.

Other symbols: COSTCVXINTCKOMCDTSLA

Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It

Johnson & Johnson (JNJ) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

7 Retirement Stocks to Buy After Age 30

Inflation, interest rate hikes, recessions. There's a lot to worry about right now.

Other symbols: AMTDEOECLMMMNKEV

3 Top Warren Buffett Stocks to Buy in This Bear Market

Their businesses are built for times like these.

Other symbols: CVXMCK

10 Stocks to Buy When They're Down

When you buy shares of stock, you become a partner in a business. Perhaps I'm stating the obvious, but I doubt all investors see their purchases that way.

COVID-19 vaccines slowly begin to roll out for young kids

Yahoo Finance's Anjalee Khemlani discusses the rollout of COVID vaccines for kids 6 months to 5 years, plus a new test that could indicate when a person needs a booster shot.

Other symbols: BNTXMRNAPFE

J&J's (JNJ) Stock Outperforms Industry YTD: Here's Why

J&J's (JNJ) Pharma unit is performing above market levels. Sales in the Consumer unit are being hurt by external supply constraints.

Bear Market 2022: Is There Anything Left to Invest In?

Bear markets often present the best investment opportunities. Consider the following strategies to profit in this 2022 bear market.

5 Warren Buffett Stocks That Can Help You Crush Historically High Inflation

Rapidly rising prices are no match for these highly profitable industry leaders.

Other symbols: CVXMASTORV

Johnson & Johnson Opens First Satellite Center for Global Health Discovery in Asia Pacific at Duke-NUS to Advance Den...

The new Satellite Center will work to accelerate discovery research against flaviviruses, including dengue, which impacts 400 million people each year This effort will build on Johnson & Johnson's decad...

3 Oversold Health Care Stocks Set for a Rebound

With so much carnage in the stock market right now, investors are rushing to the exits trying to preserve what gains they have left. In a market-wide sell-off, stocks of all stripes get sold off, regard...

Other symbols: ABTAMGN

Seven reasons the beleaguered biotech sector is now a ‘buy'

If you have the discipline to think long-term as an investor, this is the time to take advantage of the steep discounts on great biotechnology companies.

The Dow Got Crushed -- Here Are 4 Stocks That Survived the Bloodbath

The Dow Jones Industrial Average fell more than 740 points today.

Other symbols: MRKPGWMT

Recession-proof your portfolio with these blue-chip stocks

American stocks are not doing well. The tech bubble is slowly bursting while the S&P 500 index has moved to a bear market.

Other symbols: OXYXOM

2 Growth Stocks That Are Interest Rate Proof

Solid fundamentals make these stocks safe investments to buy and hold.

Other symbols: MSFT

3 Super-Safe Dividend Stocks to Buy

Dividend payments are an important source of stock-based compensation. Individual retail investors count on dividend payments for income, often when they are retired.

Other symbols: FDXLOW

5 Top-Performing Stocks Warren Buffett, Tom Gayner Agree On

According to the All-in-One Screener, a Premium feature of GuruFocus, Warren Buffett (Trades, Portfolio)'s Berkshire Hathaway Inc. ( BRK.A , Financial)( BRK.B , Financial) and Tom Gayner (Trades, Portfo...

Other symbols: CEMAMMCV

5 Warren Buffett Stocks to Buy and Never Sell

These highly profitable, time-tested stocks check all the right boxes for long-term investors.

Other symbols: AMZNMAUSBV

3 Stocks to Buy During a Recession

Altria, Verizon, and Johnson & Johnson will help you sleep better at night.

Other symbols: MOVZ

5 Starter Stocks to Generate Passive Income

Here are five simple, reliable, and successful stocks to kick-start your passive income journey.

Other symbols: KOMCDMMMPG

3 Dividend Aristocrats Suited Perfectly for Income Investors

To be a Dividend Aristocrat, a company must increase its dividend for 25 consecutive years. Additionally, the company must also be a member of the S&P 500.

Other symbols: CATKO

Is Johnson & Johnson A Recession-Proof Stock?

Johnson & Johnson (JNJ) is often considered a ‘safe haven' investment during recessions. Here's why.

Investors Heavily Search Johnson & Johnson (JNJ): Here is What You Need to Know

Recently, Zacks.com users have been paying close attention to Johnson & Johnson (JNJ). This makes it worthwhile to examine what the stock has in store.